Posted 4/5/2024
The first conference held under the auspices of Frederick National Laboratory’s (FNL’s) Scientific Standards Hub , an...
Posted 1/25/2024
Technologies invented and patented by researchers at the Frederick National Laboratory for Cancer Research are on...
Posted 1/9/2024
Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for...
All News
Patent display highlights innovation by Frederick National Laboratory researchers
Partnership Development OfficePosted 1/25/2024Technologies invented and patented by researchers at the Frederick National Laboratory for Cancer Research are on display at the laboratory’s Advanced Technology Research Facility to highlight the innovation that is integral to FNL’s mission to discover and innovate to improve human health.
“Securing a patent is a huge accomplishment in general and a major accomplishment…
Biotech Connector highlights marvels in mass spectrometry
Partnership Development OfficePosted 1/18/2024Frederick-area biotechnology professionals got an inside look at advances in mass spectrometry as part of the quarterly Biotech Connector Series at the Frederick National Laboratory for Cancer Research.
Mass spectrometry is an analytical technique that allows scientists to determine the mass, structure, and chemical properties of molecules. It is a powerful tool with…
New drug to treat HIV might also be used to block infection altogether
AIDS and Cancer Virus Program, Viral Persistence SectionPosted 1/9/2024Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for a new drug that might only need to be taken twice a year to prevent HIV infection. The drug manufacturer is planning a clinical trial.
The drug, Lenacapavir, recently approved by the Food and Drug Administration as a treatment for multi-drug resistant…
Morehouse School of Medicine biospecimens to boost diversity of cancer samples for proteogenomic analysis
Partnership Development OfficePosted 10/11/2023A national effort to understand the molecular basis of numerous cancers by analyzing proteins and genes will benefit from greater diversity in patient samples through a new agreement with the Morehouse School of Medicine, a historically Black medical school in Atlanta.
MSM joins the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC)…
AI enhances method for rapid diagnosis, potentially better treatment of endometrial cancer
Posted 10/9/2023
Artificial intelligence has helped researchers uncover potential avenues for better treatment of endometrial cancer, the most common gynecologic malignancy in the developed world and one with a worsening mortality rate, particularly among Blacks and Hispanics.
With the aid of deep learning, a type of AI, a large multi-institutional collaboration including the Frederick…
ATOM summer training program builds student skill sets and opens doors for career opportunities
Cancer Data Science InitiativesPosted 10/3/2023Three students from Butler University and Hood College participated in a 10-week virtual training at the Frederick National Laboratory for Cancer Research, learning more about tools developed by the Accelerated Therapeutics for Opportunities in Medicine (ATOM).
FNL co-founded the ATOM consortium in 2017 as a public–private collaboration with universities, other national…
2023 Technology Showcase Highlights How Partnerships Move the Science Forward
Center for Innovation and Strategic Partnerships, Partnership Development OfficePosted 9/28/2023With 100 online attendees, 180 in-person participants, 15 posters, 16 technologies, and 45 speakers, the 2023 Technology Showcase offered a whirlwind look into the biotechnology innovation happening at the Frederick National Laboratory and National Cancer Institute.
“This is a valuable event to make connections and show potential partners what we can do,” said Maggie…
Public-private partnerships key to equality and equity in research
Partnership Development OfficePosted 8/31/2023The Frederick National Laboratory’s partnerships with historically Black colleges and universities (HBCUs) came into focus at the National Institutes of Health’s Collaborative Model for Building Equality and Equity in Research Conference in July. FNL Partnership Development Office Director Maggie Scully, Ph.D. highlighted the laboratory’s experience during the session “…
Long-term data paint clearer pictures of antibody levels and potency against SARS-CoV-2
Vaccine, Immunity, and Cancer Directorate, COVID-19 Serology LaboratoryPosted 8/28/2023After three years of COVID-19, science has learned much about the disease and the virus that causes it, SARS-CoV-2. But in the bigger biological and clinical picture, there are still many unanswered questions, says Ligia Pinto, Ph.D.
That’s what keeps her group, the Vaccine, Immunity, and Cancer Directorate at Frederick National Laboratory, working hard to hunt down…
NCI and FNL Technology Showcase Returns September 6
Center for Innovation and Strategic Partnerships, Partnership Development OfficePosted 8/25/2023The National Cancer Institute and Frederick National Laboratory for Cancer Research will host the Technology Showcase on Wednesday, Sept. 6 at the FNL’s Advanced Technology Research Facility in Frederick, Md.
The seventh annual event highlights NCI and FNL inventions and capabilities available to the external healthcare and biotech communities and offers the opportunity…
Media Inquiries
For all media related questions please contact:
Mary Ellen Hackett
Manager, Communications Office